Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome - Contacts and Locations

Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00004106. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004106

Locations


United States, Connecticut
	Yale Comprehensive Cancer Center at Yale University School of Medicine
	New Haven, Connecticut, United States, 06520-8028

United States, Illinois
	Robert H. Lurie Comprehensive Cancer Center at Northwestern University
	Chicago, Illinois, United States, 60611-3013
	University of Chicago Cancer Research Center
	Chicago, Illinois, United States, 60637-1470

Sponsors and Collaborators

Robert H. Lurie Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Timothy M. Kuzel, MD	Robert H. Lurie Cancer Center